Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 3, 2010, Pages 336-338

  Rodríguez Cerrato, Violeta ^a   Gracia, Matilde ^a   del Prado, Gema ^a   Huelves, Lorena ^a   Naves, Plínio ^a   Ruiz, Vicente ^a   Ponte, Carmen ^a   Soriano, Francisco ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Antibiotic resistance; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; NOVOBIOCIN; PENICILLIN G; TELITHROMYCIN; TIGECYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG COMPETITION; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 77349097561     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.10.015     Document Type: Article

References (15)

1. Arathoon E.G., Hamilton J.R., Hench C.E., Stevens D.A. Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates. Antimicrob. Agents Chemother. 1990, 34:1655-1659.
2. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 18th informational supplement (M100-S18) 2008, CLSI, Wayne, PA.
3. Drusano G.L., Townsend R.J., Walsh T.J., Forrest A., Antal E.J., Standiford H.C. Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination. Antimicrob. Agents Chemother. 1986, 30:42-45.
4. Eliopoulos G., Moellering R.C.J. Antimicrobial combinations. Antibiotics in laboratory medicine 1996, 330-396. The Williams & Wilkins Co., Baltimore. V. Lorian (Ed.).
5. Friedland I.R., Paris M., Shelton S., McCracken G.H. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 1994, 34:231-237.
6. Gombert M.E., Aulicino T.M. Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin. Antimicrob. Agents Chemother. 1984, 26:933-934.
7. Jones R.N. Should novobiocin be clinically re-evaluated?. Diagn. Microbiol. Infect. Dis. 1989, 12:363-365.
8. Limson B.M., Romansky M.J. Novobiocin, a new antibiotic; laboratory and clinical evaluation of thirty patients with bacterial pneumonia. Antibiotic Med. Clin. Ther. 1956, 2:277-281.
9. Muñoz R., Bustamante M., de la Campa A.G. Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance. J. Bacteriol. 1995, 177:4166-4170.
10. Richter S.S., Heilmann K.P., Dohrn C.L., Riahi F., Beekmann S.E., Doern G.V. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin. Infect. Dis. 2009, 48:e23-e33.
11. Sá Figueiredo A.M., Austrian R., Urbaskova P., Teixeira L.A., Tomasz A. Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microb. Drug Res. 1995, 1:71-78.
12. Shane S.H. Novobiocin, a new antibiotic. Can. Med. Assoc. J. 1956, 75:51-52.
13. Soriano F., Cafini F., Aguilar L., Tarragó D., Alou L., Giménez M.J., Gracia M., Ponte M.C., Leu D., Pana M., Letowska I., Fenoll A. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J. Antimicrob. Chemother. 2008, 62:1234-1240.
14. Walsh T.J., Standiford H.C., Reboli A.C., John J.F., Mulligan M.E., Ribner B.S., Montgomerie J.Z., Goetz M.B., Mayhall C.G., Rimland D., Stevens D.A., Hansen S.L., Gerard G.C., Ragual R.J. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob. Agents Chemother. 1993, 37:1334-1342.
15. Welch H., Lewis C.N., Putnam L.E., Randall W.A. A study of the sensitizing potential of novobiocin. Antibiotic Med. Clin. Ther. 1956, 3:27-32.